TLR4 and sickle cell disease: Recent evidence shows that TLR4-dependent upregulation of endothelial P-selectin triggers an unconventional route of complement activation by non-covalent binding of C3 activation fragments on the surface of ECs, which mechanism contributes to liver injury in hemolytic diseases such as sickle cell disease (20).